TRACON Pharmaceuticals Inc Call to Discuss Collaborative Partnership Agreement with 3D Medicines (Beijing) Co Ltd and Jiangsu Alphamab Biopharmaceuticals Co Ltd Transcript
Greetings. Welcome to the TRACON Pharmaceuticals Conference Call. (Operator Instructions) Please note, this conference is being recorded.
At this time, I'll turn the conference over to Scott Brown, Vice President of Finance. Scott, you may begin.
Good morning, and thank you for joining us today. As a reminder, we will be making certain forward-looking statements, including statements regarding future development plans and strategy and potential benefits of our product candidates. These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. You are cautioned not to place undue reliance on these forward-looking statements, and we disclaim any obligation to update such statements.
With that, I will now turn the call over to Dr. Charles Theuer, President and CEO of TRACON. Dr. Theuer?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |